CONMED Corporation (CNMD) Insider Trading
Insiders sold $161k and bought nothing on the open market.
All of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in May 2024.
Get an email when CNMD's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Nov 21, 2025 | Richard Glaze Chief Information Officer | Sold10b5-1 plan | 257 | $41.21 | $11k | 100% | Form 4 |
| Nov 6, 2025 | Todd W Garner Executive Vice President & CFO | Sold10b5-1 plan | 3,500 | $43.00 | $151k | 66% | Form 4 |
| Sep 12, 2025 | Charles Farkas Director | SoldNo plan 2 parts | 2,000 | $53.53 average | $107k | 12% | Form 4 |
| Aug 7, 2025 | Todd W Garner Executive Vice President & CFO | SoldNo plan | 598 | $52.45 | $31k | 100% | Form 4 |
| May 5, 2025 | Charles Farkas Director | SoldNo plan | 4,000 | $56.94 | $228k | 20% | Form 4 |
| Feb 11, 2025 | Richard Glaze Chief Information Officer | SoldNo plan | 257 | $65.35 | $17k | 100% | Form 4 |
- Nov 21, 202510b5-1 planRichard GlazeChief Information Officer · sold 257 at $41.21$11k100% of stake
- Nov 6, 202510b5-1 planTodd W GarnerExecutive Vice President & CFO · sold 3,500 at $43.00$151k66% of stake
- Sep 12, 2025No planCharles FarkasDirector · sold 2,000 at avg $53.53$107k12% of stake
- Aug 7, 2025No planTodd W GarnerExecutive Vice President & CFO · sold 598 at $52.45$31k100% of stake
- May 5, 2025No planCharles FarkasDirector · sold 4,000 at $56.94$228k20% of stake
- Feb 11, 2025No planRichard GlazeChief Information Officer · sold 257 at $65.35$17k100% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Related stocks: Electromedical & Electrotherapeutic Apparatus
Spot a number that looks wrong? Check it in CNMD's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing CNMD
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.